In fusion‐positive rhabdomyosarcoma (FP‐RMS), high levels of FGFR4 expression are transcriptionally driven by the protein product of the recurrent fusion gene PAX3‐FOXO1 [16, 17]. Here, FOXO1 is linked to rhabdomyosarcoma.